Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240759 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
A Phase 2 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 2
- Development phase
- 218
- Enrollment target
NCT01240759: Completed Phase 2 study, sponsored by Shionogi.
NCT01240759 is a Phase 2 study that has completed, run by Shionogi. The registered enrollment target is 218 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01240759, a Phase 2 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 218 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.
Primary Outcome
Hemoglobin A1c
Interventions
- DRUG Metformin
- DRUG S-707106 Dose A
- DRUG S-707106 Dose B
- DRUG S-707106 Dose C
- DRUG Placebo A tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
What the finished NCT01240759 record still lists
NCT01240759 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% higher).
The record links to 0 conditions, and to 5 interventions - of which Metformin is the first listed.
NCT01240759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01240759 about?
NCT01240759 is a clinical study titled "Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy". The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.
What is the current status of trial NCT01240759?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 218 participants. The study started on 2010-10. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01240759?
The interventions under investigation include: Metformin (DRUG), S-707106 Dose A (DRUG), S-707106 Dose B (DRUG), S-707106 Dose C (DRUG), Placebo A tablet (DRUG).
Who is sponsoring clinical trial NCT01240759?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01240759's enrollment target sits among peer trials
218 284th of 2000 higher than 1,715 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia